PeptideDB

1,3,6,8-Tetrahydroxynaphthalene (1,3,6,8-THN; T4HN) 18512-30-6

1,3,6,8-Tetrahydroxynaphthalene (1,3,6,8-THN; T4HN) 18512-30-6

CAS No.: 18512-30-6

1,3,6,8-Tetrahydroxynaphthalene (T4HN) is an indispensable precursor of DHN melanin and a unique symmetric polyketide or
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

1,3,6,8-Tetrahydroxynaphthalene (T4HN) is an indispensable precursor of DHN melanin and a unique symmetric polyketide origin compound.

Physicochemical Properties


Molecular Formula C10H8O4
Molecular Weight 192.17
Exact Mass 192.042
CAS # 18512-30-6
PubChem CID 440202
Appearance Light brown to brown solid powder
Density 1.638g/cm3
Boiling Point 407.1ºC at 760mmHg
Flash Point 208.9ºC
Vapour Pressure 3.29E-07mmHg at 25°C
Index of Refraction 1.832
LogP 1.662
Hydrogen Bond Donor Count 4
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 0
Heavy Atom Count 14
Complexity 188
Defined Atom Stereocenter Count 0
SMILES

C1(O)C2C(=CC(O)=CC=2O)C=C(O)C=1

InChi Key BCMKHWMDTMUUSI-UHFFFAOYSA-N
InChi Code

InChI=1S/C10H8O4/c11-6-1-5-2-7(12)4-9(14)10(5)8(13)3-6/h1-4,11-14H
Chemical Name

naphthalene-1,3,6,8-tetrol
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro It is believed that type 1 polyketide synthase (PKS) directly produces 1,3,6,8-Tetrahydroxynaphthalene (T4HN), an early precursor of the pentaketide pathway, from malonyl-CoA and acetyl-CoA [2].
Additional Infomation Naphthalene-1,3,6,8-tetrol is a naphthalenetetrol that is naphthalene substituted by hydroxy groups at positions 1, 3, 6 and 8.
1,3,6,8-Tetrahydroxynaphthalene has been reported in Glarea lozoyensis, Nodulisporium, and other organisms with data available.

Solubility Data


Solubility (In Vitro) DMSO: 125 mg/mL (650.47 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (10.82 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 5.2037 mL 26.0186 mL 52.0373 mL
5 mM 1.0407 mL 5.2037 mL 10.4075 mL
10 mM 0.5204 mL 2.6019 mL 5.2037 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.